ASND
ASND
DK0060615755
Ascendis Pharma A/S
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 720.132.000 363.641.000
98.0%
Cost of Revenue 94.915.000 44.258.000
114.5%
Gross Profit 625.217.000 319.383.000
95.8%
761.488.000 598.146.000
27.3%
Operating Income -136.271.000 -278.763.000
51.1%
Pretax Income -212.651.000 -373.241.000
43.0%
Net Income Common Stockholders -228.034.000 -378.084.000
39.7%
-- --
--
-- --
--
ende